Van Renterghem, B.; Wozniak, A.; Tarantola, L.; Casazza, A.; Wellens, J.; Nysen, M.; Vanleeuw, U.; Lee, C.-J.; Reyns, G.; Sciot, R.;
et al. Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma. Biomedicines 2022, 10, 862.
https://doi.org/10.3390/biomedicines10040862
AMA Style
Van Renterghem B, Wozniak A, Tarantola L, Casazza A, Wellens J, Nysen M, Vanleeuw U, Lee C-J, Reyns G, Sciot R,
et al. Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma. Biomedicines. 2022; 10(4):862.
https://doi.org/10.3390/biomedicines10040862
Chicago/Turabian Style
Van Renterghem, Britt, Agnieszka Wozniak, Ludovica Tarantola, Andrea Casazza, Jasmien Wellens, Madita Nysen, Ulla Vanleeuw, Che-Jui Lee, Geert Reyns, Raf Sciot,
and et al. 2022. "Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma" Biomedicines 10, no. 4: 862.
https://doi.org/10.3390/biomedicines10040862
APA Style
Van Renterghem, B., Wozniak, A., Tarantola, L., Casazza, A., Wellens, J., Nysen, M., Vanleeuw, U., Lee, C.-J., Reyns, G., Sciot, R., Kindt, N., & Schöffski, P.
(2022). Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma. Biomedicines, 10(4), 862.
https://doi.org/10.3390/biomedicines10040862